GlassScriptPhysician profile
Joseph R Jacob
NPI 1134446891
$810.07
in general payments reported to CMS, 2019-2025
14 companies · $226 in 2025
The $226 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $186 · 2020: $65.23 · 2021: $142 · 2022: $93.64 · 2023: $37.12 · 2024: $60.56 · 2025: $226.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $298 · Education: $25.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $298.02 |
| Education | $25.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $129.17 | 2019-2025 | Dupixent |
| Genzyme Corporation | $125.71 | 2021-2025 | |
| Stryker Corporation | $121.18 | 2019-2023 | Scopis Ent |
| Intersect Ent, INC. | $101.36 | 2019-2022 | |
| Advanced Bionics, LLC | $64.31 | 2021 | |
| Acclarent, INC | $54.37 | 2019 | |
| Cochlear Americas | $49.46 | 2020-2021 | |
| Smith+Nephew, INC. | $27.68 | 2024 | |
| Glaxosmithkline, LLC. | $26.91 | 2021-2024 | Nucala |
| Integra Lifesciences Corporation | $26.44 | 2025 | Inspira Air, Acclarent Aera, Trudi Probe |
| Depuy Synthes Sales INC. | $25.89 | 2025 | Vapr |
| Merck Sharp & Dohme LLC | $25.70 | 2025 | Keytruda |
| Amgen INC. | $18.12 | 2025 | Tezspire |
| Optinose US, INC. | $13.77 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Jacob listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.